Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis C virus nonstructural proteins are a set of viral proteins produced during HCV infection that play essential roles in RNA genome replication, proteolytic processing of the viral polyprotein, and the assembly of new infectious virus particles. These proteins are generally classified as enzymes (such as proteases, helicases, and polymerases) or membrane-associated proteins that organize and facilitate the replication complex within specialized cytoplasmic membrane structures. They are intracellular targets and do not form part of the virus particle itself. Therapeutic targeting of these molecules with direct-acting antiviral drugs has revolutionized HCV treatment by achieving robust viral suppression and cure rates.
Inhibition of NS3/4A protease blocks viral polyprotein processing and replication NS5A inhibitors disrupt organization of replication complexes and viral assembly NS5B inhibitors directly inhibit the RNA-dependent RNA polymerase activity and block viral RNA synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus nonstructural proteins (HCV NS proteins).